From April 28 to 30, 2026, the 30th Anniversary Tashkent International Healthcare Exhibition (TIHE 2026) brought together government authorities, leading manufacturers, healthcare providers, and international experts at CAEx Uzbekistan. As a key professional event for Uzbekistan’s medical industry, TIHE provides an important platform for showcasing innovative healthcare technologies, exchanging industry insights, and exploring new opportunities for international collaboration.
At TIHE 2026, Bioer Technology showcased its comprehensive portfolio of molecular diagnostics products and solutions, demonstrating the company’s capabilities across PCR amplification and detection, automated nucleic acid purification, molecular diagnostics, reagents, and high-performance consumables.
The instruments on display included the GeneExplorer Thermal Cycler, QuantGene 9600 Fluorescent Quantitative Detection System, LineGene Mini S Fluorescent Quantitative Detection System, GenePure Pro Nucleic Acid Purification System, and CentriDx Automated Nucleic Acid Analyzer. Together, these products provide flexible solutions for a wide range of molecular testing workflows, from nucleic acid purification and PCR amplification to fluorescence detection and automated molecular analysis.
In addition to instruments, Bioer Technology presented a broad range of nucleic acid extraction kits designed for various sample types, along with molecular diagnostic assays covering respiratory infections, gastrointestinal infections, sexually transmitted diseases (STDs), public health, and other application areas.
The CentriDx syndrome-based multiplex panels were another highlight of the exhibition. Designed for multiplex pathogen detection, these panels provide laboratories with efficient solutions for the simultaneous detection of multiple targets, supporting streamlined molecular testing workflows. Bioer Technology also showcased its high-performance consumables, further demonstrating its comprehensive product portfolio spanning instruments, reagents, and consumables.
During the exhibition, the Bioer Technology team connected with customers, partners, and healthcare professionals from Uzbekistan and other international markets. The event provided valuable opportunities to exchange ideas, better understand evolving market needs, and explore new possibilities for cooperation in molecular diagnostics and laboratory technologies.
Looking ahead, Bioer Technology will continue to focus on innovation in molecular diagnostics and life science technologies, providing comprehensive and reliable products and solutions for customers worldwide.
Through continuous technological development and global collaboration, Bioer Technology looks forward to working with partners around the world to advance molecular diagnostics and contribute to more efficient and accessible healthcare solutions.
